Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
22.29
-0.51 (-2.24%)
At close: Jul 20, 2026, 4:00 PM EDT
22.19
-0.10 (-0.47%)
After-hours: Jul 20, 2026, 7:34 PM EDT

Syndax Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-243.25-285.42-318.76-209.36-149.3424.93
Depreciation & Amortization
-0.010.010.010.030.04
Stock-Based Compensation
49.1847.543.0330.9516.0213.32
Other Adjustments
-6.99-5.75-12.45-14.06-2.050.44
Change in Receivables
-22.39-30.39-7.6---
Changes in Inventories
-29.96-32.09-0.37---
Changes in Accounts Payable
0.84.951.675.61-1.322.16
Changes in Accrued Expenses
16.3542.1719.1414.879.422.77
Changes in Unearned Revenue
------13.13
Changes in Other Operating Activities
-45.74-63.49-0.0311.38-6.45-1.39
Operating Cash Flow
-278.16-322.98-274.9-160.6-133.6829.13
Capital Expenditures
--0.19----0.13
Sale of Property, Plant & Equipment
----0.23-
Purchases of Investments
-224.66-195.81-557.05-354.61-495.35-294.72
Proceeds from Sale of Investments
459.13486.03337.28472.22308.93253.98
Investing Cash Flow
234.28290.04-219.78117.61-186.19-40.87
Long-Term Debt Repaid
-----21-
Net Long-Term Debt Issued (Repaid)
-----21-
Issuance of Common Stock
20.6613.68353.37264.13193.25117.89
Net Common Stock Issued (Repurchased)
20.6613.68353.37264.13193.25117.89
Other Financing Activities
-----0.58
Financing Cash Flow
20.6613.68353.37264.13172.25118.46
Net Cash Flow
-23.22-19.27-141.31221.14-147.61106.72
Free Cash Flow
-278.16-323.17-274.9-160.6-133.6829
FCF Margin
-127.94%-187.50%-1160.91%--20.76%
Free Cash Flow Per Share
-3.19-3.73-3.21-2.28-2.200.54
Levered Free Cash Flow
-301.8-334.06-298.34-177.49-168.6515.24
Unlevered Free Cash Flow
-282.08-321.73-319.26-198.08-150.0716.54
SEC Filings: 10-K · 10-Q